EUVIMEDEUVIMED entdecken
Open Access

Mutation-guided vaccine design: A process for developing boosting immunogens for HIV broadly neutralizing antibody induction

Kevin Wiehe, Kevin O Saunders, Victoria Stalls, Derek W Cain, Sravani Venkatayogi, Joshua S Martin Beem, Madison Berry, Tyler Evangelous, Rory Henderson, Bhavna Hora, Shi-Mao Xia, Chuancang Jiang und 23 weitere

Cell Host & Microbe · 2024

DOI: 10.1016/j.chom.2024.04.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Host & Microbe, 2024. Verfasst von Kevin Wiehe und 34 weiteren Autor:innen. Beteiligte Einrichtung: Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA; Department of Medicine, Duke University School of Medicine, …. Hauptthemen laut MEDLINE: AIDS Vaccines, HIV Antibodies, HIV-1, Antibodies, Neutralizing. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, Division of Intramural Research, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A major goal of HIV-1 vaccine development is the induction of broadly neutralizing antibodies (bnAbs). Although success has been achieved in initiating bnAb B cell lineages, design of boosting immunogens that select for bnAb B cell receptors with improbable mutations required for bnAb affinity maturation remains difficult. Here, we demonstrate a process for designing boosting immunogens for a V3-glycan bnAb B cell lineage. The immunogens induced affinity-matured antibodies by selecting for functional improbable mutations in bnAb precursor knockin mice. Moreover, we show similar success in prime and boosting with nucleoside-modified mRNA-encoded HIV-1 envelope trimer immunogens, with improved selection by mRNA immunogens of improbable mutations required for bnAb binding to key envelope glycans. These results demonstrate the ability of both protein and mRNA prime-boost immunogens for selection of rare B cell lineage intermediates with neutralizing breadth after bnAb precursor expansion, a key proof of concept and milestone toward development of an HIV-1 vaccine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AIDS VaccinesHIV AntibodiesHIV-1Antibodies, NeutralizingB-LymphocytesAnimalsMiceHumansHIV InfectionsBroadly Neutralizing AntibodiesMutationVaccine DevelopmentImmunization, Secondaryenv Gene Products, Human Immunodeficiency Virus

Stichwörter der Autor:innen

B cell developmentHIV vaccineaffinity maturationbroadly neutralizing antibodiesimprobable mutationsmRNA vaccinevaccine design

Substanzen

AIDS VaccinesHIV AntibodiesAntibodies, NeutralizingBroadly Neutralizing Antibodiesenv Gene Products, Human Immunodeficiency Virus

Autor:innen und Institutionen

  • Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA. Electronic address: kevin.wiehe@duke.edu.
  • Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA; Department of Surgery, Duke University School of Medicine, Durham, NC 27710, USA; Department of Microbiology and Molecular Genetic…
  • Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.
  • Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA.
  • Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA; Department of Surgery, Duke University School of Medicine, Durham, NC 27710, USA.
  • Corporate Research Materials Lab, 3M Company, St. Paul, MN 55144, USA.

Förderung

  • NIAID NIH HHS
  • Division of Intramural Research
  • National Institute of Allergy and Infectious Diseases
  • U.S. Department of Health and Human Services
  • 3M
  • National Institutes of Health

Zitieren

APA

Wiehe, K., Saunders, K. O., Stalls, V., Cain, D. W., Venkatayogi, S., Martin Beem, J. S., Berry, M., Evangelous, T., Henderson, R., Hora, B., Xia, S. M., Jiang, C., Newman, A., Bowman, C., Lu, X., Bryan, M. E., Bal, J., Sanzone, A., Chen, H., …, & Haynes, B. F. (2024). Mutation-guided vaccine design: A process for developing boosting immunogens for HIV broadly neutralizing antibody induction. Cell Host & Microbe. https://doi.org/10.1016/j.chom.2024.04.006

Vancouver

Wiehe K, Saunders KO, Stalls V, Cain DW, Venkatayogi S, Martin Beem JS, et al. Mutation-guided vaccine design: A process for developing boosting immunogens for HIV broadly neutralizing antibody induction. Cell Host & Microbe. 2024. doi:10.1016/j.chom.2024.04.006

BibTeX
@article{Wiehe2024,
  author = {Wiehe, Kevin and Saunders, Kevin O and Stalls, Victoria and Cain, Derek W and Venkatayogi, Sravani and Martin Beem, Joshua S and Berry, Madison and Evangelous, Tyler and Henderson, Rory and Hora, Bhavna and Xia, Shi-Mao and Jiang, Chuancang and Newman, Amanda and Bowman, Cindy and Lu, Xiaozhi and Bryan, Mary E and Bal, Joena and Sanzone, Aja and Chen, Haiyan and Eaton, Amanda and Tomai, Mark A and Fox, Christopher B and Tam, Ying K and Barbosa, Christopher and Bonsignori, Mattia and Muramatsu, Hiromi and Alam, S Munir and Montefiori, David C and Williams, Wilton B and Pardi, Norbert and Tian, Ming and Weissman, Drew and Alt, Frederick W and Acharya, Priyamvada and Haynes, Barton F},
  title = {Mutation-guided vaccine design: A process for developing boosting immunogens for HIV broadly neutralizing antibody induction},
  journal = {Cell Host & Microbe},
  year = {2024},
  doi = {10.1016/j.chom.2024.04.006}
}
Kostenlos starten →